|Faculty members for the First Johnson & Johnson Institute GERD Symposium in Hamburg, Germany.|
Occasional heartburn is usually treatable with over-the-counter medication and/or lifestyle modification. But for patients with gastroesophageal reflux disease (GERD), the acid reflux flare-ups tend to be more frequent, painful and don’t always respond well to medications. If not treated, GERD can injure the esophagus and lead to a pre-cancerous condition known as Barrett's esophagus.
Helping patients get the right treatment at the right time was the focus of the first EMEA GERD Symposium at the Johnson & Johnson Institute in Hamburg, Germany. This highly interactive forum brought together a multi-disciplinary group of expert surgeons specialized in reflux surgery, gastroenterologists and allied health professionals. Through a mix of debates, plenary presentations, and workshops, symposium attendees focused on the evolution of GERD treatment and reflux surgery.
Lifestyle changes and medications to alleviate the symptoms of GERD do not work for a number of patients. The good news is that today there are minimally-invasive surgical procedures to help patients find relief from GERD. These innovative procedures can be performed on an outpatient basis with a short recovery time.
At the Symposium, the expert faculty led attendees in education and training sessions about proper patient selection for surgical treatment and pre, peri and post-operative management of patients in a multidisciplinary setting to optimize outcomes. The program consisted of a plenary session with a panel discussion and tailor-made workshops.
“Millions of patients continue to suffer from GERD symptoms even when taking medication,” said Sarah Vandenzavel, Professional Education Manager. “The Johnson & Johnson Institute is committed to collaborating with the surgical and medical community to help more patients access the benefits of minimally-invasive surgical options to improve the quality of their life and avoid the potential consequences of not treating the disease.”